Page 1

CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

DAILY EQUITY REPORT 10TH OCT 2019

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

Daily Equity Report

INDIAN FACE

INDIAN MARKET CLOSE

PREVIOUS

!

INDIAN EQUITY BENCHMARK- The market rebounded sharply after a steep fall in the last six sessions, with the

Nifty50 reclaiming 11,300 levels despite waning optimism over US-China trade meeting that will be held on October 10CLOSE

PREVIOUS

11. The benchmark indices had fallen nearly 4 percent in the

21587.7

NIKKEI

previous six days in a row, while BSE Smallcap index slipped 5.4 percent and Midcap index dropped 4.7 percent after

2021.73 SECTORIAL INDICES CLOSE

CHANGE (%)

11423.65

1.65

9177.65

1.52

4306.50

2.00

5861.65

1.60

28785

3.67

rising 6-8 percent .

! !

GLOBAL FACE Asian Market- Asian markets finished mixed as of the most recent closing prices. The Shanghai Composite gained 0.39%,

while the Nikkei 225 led the Hang Seng lower. They fell 0.61% and 0.54% respectively.

!

U.S. Market – North and South American markets finished broadly lower on Tuesday with shares in U.S. leading the

region. The S&P 500 is down 1.56% while Mexico's IPC is off

TOP GAINERS CLOSE

CHANGE (%)

1,309.50

5.52

259.20

5.34

BHARTIARTL

359.40

5.23

SBIN

261.80

5.10

0.97% and Brazil's Bovespa is lower by 0.59%.

!

European markets- European markets are mixed. The DAX is higher by 0.84%, while the CAC 40 is leading the FTSE 100

lower. They are down 0.63% and 0.35% respectively.

TOP LOSERS CLOSE

CHANGE (%)

YESBANK

43.30

-5.15

HEROMOTOC

2,599.00

-2.80

245.55

-2.37

1,230.40

-2.27

TITAN

Daily Equity Report Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

NIFTY SPOT

MARKET MOVERS UPSIDE

STRATEGY

(%)

423.35

3.70

675.00

4.01

M&M

576.90

4.33

SBIN

261.80

5.10

PIVOT POINTS P R1

10915

11036

11081

11157

11202

S1-11081 S2-11036

R2

11278

11399

R1-11202 R2-11278

(%) -0.43

ONCG

-0.73 ZEEL

-2.80

TCS

-1.95

NET SELL (CR) FII

3517.36

DII

3286.35 NSE TOTALS BULLISH PIVOT POINTS P R1

26122

NIFTY 1

27337

BANK NIFTY

28115

28552

S1-28115 S2-27337

29330

R3

29767

30982

R1-29330 R2-29767

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

Daily Equity Report

MARKET TALKS

Cabinet hikes dearness allowance by 5%, brings cheer to employees, pensioners

Manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.

With the Union Cabinet clearing a proposal to hike the

The group now has 273 approvals and has so far filed

dearness allowance (DA) by 5% and the hiked rate will be

over 360 ANDAs since the commencement of the filing

applicable retrospectively from July this year. The move

process in FY 2003-04.

raises dearness allowance to 17% from 12% and is likely to benefit 50 lakh government employees and 62 lakh pensioners, Information and Broadcasting Minister Prakash Javadekar said while briefing media after a Union Cabinet meeting today.

Dr Reddys receives EIR from USFDA for Bollaram facility

!

Dr Reddys Laboratories informed the exchanges regarding the audit of its API manufacturing plant 2 at Bollaram, Hyderabad The company said that it has received the Establishment Inspection Report (EIR) from USFDA, for the above-referred facility, indicating closure of the audit and the inspection classification of this facility

! !

is determined as Voluntary Action Initiated (VAI)..

Zydus gets USFDAs final approval for Colesevelam Hydrochloride Tablets Zydus Cadila has received the final approval from the USFDA to

market Colesevelam Hydrochloride Tablets, (US RLD - Welchol), 625 mg. This medication is used along with a proper diet and exercise, to lower cholesterol in people with high levels of cholesterol in the blood.

Daily Equity Report

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

NAME OF THE STOCK

: VENKEYS

DATE

: 10/10/2019

SEGMENT

: CASH

CHART TYPE

: Candlestick

EXCHANGE

: NSE

TECHNICAL INDICATORS USED

: VOLUME.MACD, RSI.

CHART

INVESTMENT ADVICE: CALL CS CALL:- BUY VENKEYS CASH NR CMP1643 TGT 1683 SL 1613

RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk.

CapitalStars Financial Research Private Ltd., Reserves all Rights.

INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:Mcx Tips Financial advisory company Sharemarket company Stock Cash Intraday

Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647


CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME

NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE

Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727

Report Is Checked by Investment Advisor:

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

Profile for CapitalStars

Daily Equity Report 10 OCT 2019  

Bullion Premium is one of our premium services. In this service, we provide 3-5 calls in MCX include mcx commodity tips, MCX Bullions, and M...

Daily Equity Report 10 OCT 2019  

Bullion Premium is one of our premium services. In this service, we provide 3-5 calls in MCX include mcx commodity tips, MCX Bullions, and M...

Advertisement